Wuppertal, Germany

Heike Neumann

This inventor holds 3 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Adverio Pharma Gmbh, Bayer Pharma Aktiengesellschaft. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heike Neumann. Retrieved from https://idiyas.com/inventor/heike-neumann-4o4mndny

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Heike Neumann: Pioneering Innovations in Pharmaceutical Compounds

Introduction: Heike Neumann, a prominent inventor based in Wuppertal, Germany, has made significant contributions to the field of pharmaceuticals. With two patents to her name, she has demonstrated a commitment to improving active compound products and their applications in medicine.

Latest Patents: Among her noteworthy inventions, Heike Neumann's first patent involves a novel active compound, methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate. This innovative product boasts improved properties such as enhanced isolability, dischargeability, and micronizability, alongside effective production and formulation processes. Her second patent focuses on solid pharmaceutical dosage forms for oral administration, which comprise sodium 1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-1H-pyrazol-5-olate. This invention highlights the active ingredient's release mechanisms and its potential use in treating heart failure, anemia, chronic renal disorders, and various cardiovascular issues.

Career Highlights: Heike Neumann has built her career at reputable companies, notably Bayer Pharma and Adverio Pharma. During her tenure at these organizations, she has been at the forefront of pharmaceutical development, utilizing her expertise to create innovative solutions for complex medical needs.

Collaborations: Throughout her career, Heike has collaborated with notable colleagues, including Klaus Benke and Michael Formell. Their collective efforts have led to advancements in pharmaceutical formulations and the ongoing pursuit of innovative treatments for patients.

Conclusion: Heike Neumann's contributions to the field of pharmaceuticals underscore her role as a trailblazer in innovation. With her impressive patent portfolio and collaborative spirit, she continues to influence the development of vital medications, improving the quality of life for many. Her work exemplifies the importance of creativity and research in the ongoing quest for better healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…